At the time of writing, Structure Therapeutics Inc ADR [GPCR] stock is trading at $22.57, up 6.92%. An important factor to consider is whether the stock is rising or falling in short-term value. The GPCR shares have gain 5.37% over the last week, with a monthly amount drifted -0.66%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Stifel started tracking the stock with Buy rating on January 08, 2025, and set its price target to $50. On December 04, 2024, H.C. Wainwright initiated with a Buy rating and assigned a price target of $80 on the stock. Morgan Stanley started tracking the stock assigning a Overweight rating and suggested a price target of $118 on September 23, 2024. JP Morgan initiated its recommendation with a Overweight and recommended $65 as its price target on May 21, 2024. Cantor Fitzgerald started tracking with a Overweight rating for this stock on April 09, 2024, and assigned it a price target of $65. In a note dated October 19, 2023, JMP Securities initiated an Mkt Outperform rating and provided a target price of $90 on this stock.
For the past year, the stock price of Structure Therapeutics Inc ADR fluctuated between $19.39 and $62.74. Currently, Wall Street analysts expect the stock to reach $118 within the next 12 months. Structure Therapeutics Inc ADR [NASDAQ: GPCR] shares were valued at $22.57 at the most recent close of the market. An investor can expect a potential return of 422.82% based on the average GPCR price forecast.
Analyzing the GPCR fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.14, Equity is -0.16 and Total Capital is -0.18. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 21.18 points at the first support level, and at 19.80 for the second support level. However, for the 1st resistance point, the stock is sitting at 23.72, and for the 2nd resistance point, it is at 24.87.
Ratios To Look Out For
It is important to note that Structure Therapeutics Inc ADR [NASDAQ:GPCR] has a current ratio of 24.74. On the other hand, the Quick Ratio is 24.74, and the Cash Ratio is 4.71.
